Epstein–Barr virus microRNAs reduce immune surveillance by virus-specific CD8+T cells
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epstein–Barr virus microRNAs reduce immune surveillance by virus-specific CD8+T cells
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 113, Issue 42, Pages E6467-E6475
Publisher
Proceedings of the National Academy of Sciences
Online
2016-10-04
DOI
10.1073/pnas.1605884113
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epstein-Barr viral miRNAs inhibit antiviral CD4 + T cell responses targeting IL-12 and peptide processing
- (2016) Takanobu Tagawa et al. JOURNAL OF EXPERIMENTAL MEDICINE
- K1 and K15 of Kaposi's Sarcoma-Associated Herpesvirus Are Partial Functional Homologues of Latent Membrane Protein 2A of Epstein-Barr Virus
- (2015) Lisa Steinbrück et al. JOURNAL OF VIROLOGY
- The Missing Link in Epstein-Barr Virus Immune Evasion: the BDLF3 Gene Induces Ubiquitination and Downregulation of Major Histocompatibility Complex Class I (MHC-I) and MHC-II
- (2015) Laura L. Quinn et al. JOURNAL OF VIROLOGY
- Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells by CD8+ T Cells
- (2015) Chiara Rancan et al. PLoS Pathogens
- Viral Inhibition of the Transporter Associated with Antigen Processing (TAP): A Striking Example of Functional Convergent Evolution
- (2015) Marieke C. Verweij et al. PLoS Pathogens
- IL-12 and type I interferon prolong the division of activated CD8 T cells by maintaining high-affinity IL-2 signaling in vivo
- (2013) Gabriel R. Starbeck-Miller et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Virus-Encoded microRNAs: An Overview and a Look to the Future
- (2013) Rodney P. Kincaid et al. PLoS Pathogens
- EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency
- (2012) Kasandra J Riley et al. EMBO JOURNAL
- Cutting Edge: miR-223 and EBV miR-BART15 Regulate the NLRP3 Inflammasome and IL-1 Production
- (2012) M. Haneklaus et al. JOURNAL OF IMMUNOLOGY
- Are membrane proteins favored over cytosolic proteins in TAP-independent processing pathways?
- (2012) Margarita Del Val et al. MOLECULAR IMMUNOLOGY
- Viral interference with antigen presentation: Trapping TAP
- (2012) Maaike E. Ressing et al. MOLECULAR IMMUNOLOGY
- RNAs in Epstein-Barr virions control early steps of infection
- (2012) S. Jochum et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The EBV Immunoevasins vIL-10 and BNLF2a Protect Newly Infected B Cells from Immune Recognition and Elimination
- (2012) Simon Jochum et al. PLoS Pathogens
- The Members of an Epstein-Barr Virus MicroRNA Cluster Cooperate To Transform B Lymphocytes
- (2011) R. Feederle et al. JOURNAL OF VIROLOGY
- The Lytic Phase of Epstein-Barr Virus Requires a Viral Genome with 5-Methylcytosine Residues in CpG Sites
- (2011) M. Kalla et al. JOURNAL OF VIROLOGY
- Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs
- (2011) David M Garcia et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- A Viral microRNA Cluster Strongly Potentiates the Transforming Properties of a Human Herpesvirus
- (2011) Regina Feederle et al. PLoS Pathogens
- A Novel Persistence Associated EBV miRNA Expression Profile Is Disrupted in Neoplasia
- (2011) Jin Qiu et al. PLoS Pathogens
- Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells
- (2010) A. Moosmann et al. BLOOD
- Systematic Analysis of Viral and Cellular MicroRNA Targets in Cells Latently Infected with Human γ-Herpesviruses by RISC Immunoprecipitation Assay
- (2010) Lars Dölken et al. Cell Host & Microbe
- Toll-Like Receptor Agonists Synergistically Increase Proliferation and Activation of B Cells by Epstein-Barr Virus
- (2010) S. Iskra et al. JOURNAL OF VIROLOGY
- The Epstein-Barr Virus-Encoded BILF1 Protein Modulates Immune Recognition of Endogenously Processed Antigen by Targeting Major Histocompatibility Complex Class I Molecules Trafficking on both the Exocytic and Endocytic Pathways
- (2010) J. Zuo et al. JOURNAL OF VIROLOGY
- Micro RNAs of Epstein-Barr Virus Promote Cell Cycle Progression and Prevent Apoptosis of Primary Human B Cells
- (2010) Eri Seto et al. PLoS Pathogens
- Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation
- (2009) O. Landgren et al. BLOOD
- Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
- (2009) H. E. Heslop et al. BLOOD
- Diverse Herpesvirus MicroRNAs Target the Stress-Induced Immune Ligand MICB to Escape Recognition by Natural Killer Cells
- (2009) Daphna Nachmani et al. Cell Host & Microbe
- Specific Targeting of the EBV Lytic Phase Protein BNLF2a to the Transporter Associated with Antigen Processing Results in Impairment of HLA Class I-Restricted Antigen Presentation
- (2009) D. Horst et al. JOURNAL OF IMMUNOLOGY
- Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells
- (2009) Takeshi Haraguchi et al. NUCLEIC ACIDS RESEARCH
- The Epstein-Barr Virus G-Protein-Coupled Receptor Contributes to Immune Evasion by Targeting MHC Class I Molecules for Degradation
- (2009) Jianmin Zuo et al. PLoS Pathogens
- Stage-Specific Inhibition of MHC Class I Presentation by the Epstein-Barr Virus BNLF2a Protein during Virus Lytic Cycle
- (2009) Nathan P. Croft et al. PLoS Pathogens
- EBV MicroRNAs in Primary Lymphomas and Targeting of CXCL-11 by ebv-mir-BHRF1-3
- (2008) T. Xia et al. CANCER RESEARCH
- Features of TAP-independent MHC class I ligands revealed by quantitative mass spectrometry
- (2008) Andreas O. Weinzierl et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Conditional Immortalization of Human B Cells by CD40 Ligation
- (2008) Martina Wiesner et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search